Association of airway cathepsin B and S with inflammation in cystic fibrosis

Irreversible tissue damage within the cystic fibrosis (CF) lung is mediated by proteolytic enzymes during an inflammatory response. Serine proteinases, in particular neutrophil elastase (NE), have been implicated however, members of the cysteine proteinase family may also be involved. The aim of this study was to determine cathepsin B and S levels in cystic fibrosis (CF) sputum and to assess any relationship to recognized markers of inflammation such as sputum NE, interleukin‐8 (IL‐8), tumor necrosis factor alpha (TNF‐α), urine TNF receptor 1 (TNFr1), plasma IL‐6, and serum C‐reactive protein (CRP). Proteinase activities were measured in the sputum of 36 clinically stable CF patients using spectrophotometric and fluorogenic assays. Immunoblots were also used to confirm enzyme activity data. All other parameters were measured by ELISA. Patients had a mean age of 27.2 (8.2) years, FEV. of 1.6 (0.79) L and BMI of 20.7 (2.8). Both cathepsin B and S activities were detected in all samples, with mean concentrations of 18.0 (13.5) µg/ml and 1.6 (0.88) µg/ml, respectively and were found to correlate not only with each other but with NE, TNF‐α and IL‐8 (in all cases . < 0.05). Airway cathepsin B further correlated with circulatory IL‐6 and CRP however, no relationship for either cathepsin was observed with urine TNFr1. This data indicates that cathepsin B and S may have important roles in the pathophysiology of CF lung disease and could have potential as markers of inflammation in future studies. Pediatr. Pulmonol. 2010; 45:860–868. © 2010 Wiley‐Liss, Inc.

[1]  B. Fischer,et al.  Proteases and cystic fibrosis. , 2008, The international journal of biochemistry & cell biology.

[2]  F. Veillard,et al.  Lung cysteine cathepsins: intruders or unorthodox contributors to the kallikrein-kinin system? , 2008, The international journal of biochemistry & cell biology.

[3]  N. McElvaney,et al.  Neutrophil Elastase Up-Regulates Cathepsin B and Matrix Metalloprotease-2 Expression1 , 2007, The Journal of Immunology.

[4]  V. Bindokas,et al.  CFTR regulates phagosome acidification in macrophages and alters bactericidal activity , 2006, Nature Cell Biology.

[5]  Christine T. N. Pham,et al.  Neutrophil serine proteases: specific regulators of inflammation , 2006, Nature Reviews Immunology.

[6]  T. Welte,et al.  Proteases and their role in chronic inflammatory lung diseases. , 2006, Current drug targets.

[7]  B. Turk,et al.  Cysteine cathepsins in the immune response. , 2006, Tissue antigens.

[8]  M. Maurel,et al.  Cysteine cathepsins in human silicotic bronchoalveolar lavage fluids. , 2006, Biochimica et biophysica acta.

[9]  M. Martino,et al.  Active cathepsins B, H, K, L and S in human inflammatory bronchoalveolar lavage fluids , 2006, Biology of the cell.

[10]  J. Pober,et al.  The Cathepsin B Death Pathway Contributes to TNF Plus IFN-γ-Mediated Human Endothelial Injury1 , 2005, The Journal of Immunology.

[11]  J. Elborn,et al.  Neutrophil cell death, activation and bacterial infection in cystic fibrosis , 2005, Thorax.

[12]  N. McElvaney,et al.  Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. , 2004, The Journal of infectious diseases.

[13]  Izabela Berdowska,et al.  Cysteine proteases as disease markers. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[14]  J. Elborn,et al.  Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa , 2003, European Respiratory Journal.

[15]  R. Levine,et al.  Inactivation of Human β-Defensins 2 and 3 by Elastolytic Cathepsins1 , 2003, The Journal of Immunology.

[16]  R. Levine,et al.  Cathepsin B, L, and S Cleave and Inactivate Secretory Leucoprotease Inhibitor* , 2001, The Journal of Biological Chemistry.

[17]  M. Dodd,et al.  Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic , 2001, The Lancet.

[18]  P. Wolters,et al.  Importance of lysosomal cysteine proteases in lung disease , 2000, Respiratory research.

[19]  S. Weiss,et al.  Regulation of Elastinolytic Cysteine Proteinase Activity in Normal and Cathepsin K–Deficient Human Macrophages , 2000, The Journal of experimental medicine.

[20]  R. Stockley.  Neutrophils and protease/antiprotease imbalance. , 1999, American journal of respiratory and critical care medicine.

[21]  P. Libby,et al.  Cystatin C deficiency in human atherosclerosis and aortic aneurysms. , 1999, The Journal of clinical investigation.

[22]  B. Wiederanders,et al.  The half-life of human procathepsin S. , 1999, European journal of biochemistry.

[23]  H. Watari,et al.  Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells. , 1999, The American journal of pathology.

[24]  T. Betsuyaku,et al.  Cysteine proteinases and cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema. , 1998, The European respiratory journal.

[25]  P. Wolters,et al.  Regulated Expression, Processing, and Secretion of Dog Mast Cell Dipeptidyl Peptidase I* , 1998, The Journal of Biological Chemistry.

[26]  R. Mitchell,et al.  Cathepsin S activity regulates antigen presentation and immunity. , 1998, The Journal of clinical investigation.

[27]  J. Elborn,et al.  Circulating immunoreactive interleukin-6 in cystic fibrosis. , 1998, American journal of respiratory and critical care medicine.

[28]  C. Iacobuzio-Donahue,et al.  Elevations in Cathepsin B Protein Content and Enzyme Activity Occur Independently of Glycosylation during Colorectal Tumor Progression* , 1997, The Journal of Biological Chemistry.

[29]  H. Ploegh,et al.  Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. , 1996, Immunity.

[30]  S. Weiss,et al.  Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Crystal,et al.  Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. , 1994, American journal of respiratory and critical care medicine.

[32]  B. Walker,et al.  Identification and characterization of the cysteine and serine proteinases of the trematode, Haplometra cylindracea and determination of their haemoglobinase activity , 1994, Parasitology.

[33]  J. Travis,et al.  The isoforms of human neutrophil elastase and cathepsin G differ in their carbohydrate side chain structures. , 1993, Biological chemistry Hoppe-Seyler.

[34]  A. Warfel,et al.  Cystatin C and Cathepsin B Production by Alveolar Macrophages From Smokers and Nonsmokers , 1991, Journal of leukocyte biology.

[35]  T. Libermann,et al.  Activation of interleukin-6 gene expression through the NF-kappa B transcription factor , 1990, Molecular and cellular biology.

[36]  A. Barrett,et al.  A catalytically active high-Mr form of human cathepsin B from sputum. , 1988, The Biochemical journal.

[37]  R. Stern,et al.  Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. , 1985, The American review of respiratory disease.

[38]  R. Stockley,et al.  Cathepsin B-like cysteine proteinase activity in sputum and bronchoalveolar lavage samples: relationship to inflammatory cells and effects of corticosteroids and antibiotic treatment. , 1985, Clinical science.

[39]  E. Shaw,et al.  Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases. , 1981, The Journal of biological chemistry.

[40]  J. Pober,et al.  The cathepsin B death pathway contributes to TNF plus IFN-gamma-mediated human endothelial injury. , 2005, Journal of immunology.

[41]  R. Levine,et al.  Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins. , 2003, Journal of immunology.

[42]  H. Chapman,et al.  Emerging roles for cysteine proteases in human biology. , 1997, Annual review of physiology.

[43]  M. Konstan,et al.  Infection and inflammation of the lung in cystic fibrosis , 1993 .

[44]  V. Turk,et al.  Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients. , 1993, Cancer detection and prevention.

[45]  H. Kirschke,et al.  Secretion of a latent, acid activatable cathepsin L precursor by human non-small cell lung cancer cell lines. , 1993, Oncology research.

[46]  M. Abrahamson,et al.  Levels of neutrophil elastase and cathepsin B activities, and cystatins in human sputum: relationship to inflammation. , 1990, Scandinavian journal of clinical and laboratory investigation.